Science Explorer Back to mapMap
Discussion
Researcher · University of Strathclyde · United Kingdom

Carla B. Roces

Carla B. Roces publishes mostly in Biomedical Engineering, Molecular Biology and Immunology, on topics such as Microfluidic and Capillary Electrophoresis Applications, Nanoparticle-Based Drug Delivery and Lipid Membrane Structure and Behavior.

OpenAlex
World rank
#1,466,083
of 7,710,434 ranked researchers
Rank in United Kingdom
#112,992
of 367,258
Works
17
Citations
1.3k
Citations per work
75.1
h-index
15
i10-index 15Top 37% in Biomedical Engineering
Carla B. Roces

What does Carla B. Roces research?

Carla B. Roces's work is mostly in Engineering (31%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (12%).

Physical Sciences: 7 works · 42.8% of their workEngineering: 5 works · 30.6% of their workBiomedical Engineering: 5 works · 30.6% of their workMaterials Science: 2 works · 12.2% of their workBiomaterials: 2 works · 10.2% of their workMaterials Chemistry: 0 works · 2.0% of their workLife Sciences: 7 works · 38.7% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 22.4% of their workMolecular Biology: 4 works · 22.4% of their workImmunology and Microbiology: 2 works · 12.2% of their workImmunology: 2 works · 12.2% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 4.1% of their workPharmaceutical Science: 1 works · 4.1% of their workEverything else: 3 works · 18.5% of their workTHEIR WORKCarla B. Roces17works
Life Sciences39%Physical Sciences43%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Engineering530.6%
    2. Materials Science212.2%
    1. Biochemistry, Genetics and Molecular Biology422.4%
    2. Immunology and Microbiology212.2%
    3. Pharmacology, Toxicology and Pharmaceutics14.1%
  3. Everything else318.5%
  1. 1Biomedical Engineering31% of their works
  2. 2Molecular Biology22% of their works
  3. 3Immunology12% of their works
  4. 4Biomaterials10% of their works
  5. 5Pharmaceutical Science4% of their works
  6. 6Materials Chemistry2% of their works

Research topics

Which keywords describe Carla B. Roces's research?

The keywords of their largest research topics: Biomedical Applications, Drug Delivery, Nanoparticles, Cancer Therapy, Lab-on-a-Chip, Nanocarriers, Poly(dimethylsiloxane) and Lipid Rafts.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Biomedical Applications82 topics
  2. Drug Delivery72 topics
  3. Nanoparticles72 topics
  4. Cancer Therapy51 topic
  5. Lab-on-a-Chip51 topic
  6. Nanocarriers51 topic
  7. Poly(dimethylsiloxane)51 topic
  8. Lipid Rafts41 topic
  9. Membrane Lipids41 topic
  10. Droplet Formation31 topic
  11. Microfluidics31 topic
  12. Chitosan21 topic
  13. Dendritic Cells21 topic
  14. Immunity21 topic
  15. Inflammasome21 topic
  16. Mucosal21 topic
  17. NLRP321 topic
  18. RNA Interference21 topic
  19. siRNA Delivery21 topic

Where does Carla B. Roces work?

Carla B. Roces's main affiliation in the publication record is University of Strathclyde, United Kingdom.

How many publications and citations does Carla B. Roces have?

OpenAlex counts 17 works and 1,276 citations for Carla B. Roces, an h-index of 15, ranking #1,466,083 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Carla B. Roces. Posts are plain text and can be reported.